Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,708.00    -40.00 (-1.07%)
Bid:
3,714.00
Ask:
3,750.00
Spread: 36.00 (0.969%)
Market Cap: £1.04b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Holding(s) in Company

5 Nov 2007 16:12

4imprint Group PLC05 November 2007 TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES (1). Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached (ii): 4imprint Group PLC 2. Reason for the notification (yes/no): An acquisition or disposal of voting rights: (Yes) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation (iii): Aberforth Partners LLP 4. Full name of shareholder(s) (if different from 3.) (iv): Share holder Shares 1. Aberforth Smaller Companies Trust plc 1,915,800 2. Aberforth UK Small Companies Fund 1,687,900 3. The Church Commissioners for England 327,400 4. Aberforth Geared Capital & Income Trust plc 274,400 1,2,4 = registered in the name of Nortrust Nominees Ltd A/c Aberfth, 3 =The Church Commissioners for England (Chase GIS) Nominees Ltd 5. Date of the transaction and date on which the threshold is crossed or reachedif different) (v): 02/11/2007 6. Date on which issuer notified: 05/11/2007 7. Threshold(s) that is/are crossed or reached: 16% 8. Notified details: A: Voting rights attached to shares Class/type of shares Situation previous to Resulting situation after the triggering transaction (vii) the Triggering If possible using the transaction (vi) ISIN CODE Number of Number of Number of Number of voting % of voting rights shares voting rights Shares rights (ix) (vii) Direct (x) Indirect (xi) Direct Indirect Ordinary 4,057,400 4,057,400 4,205,500 N/A 4,205,500 N/A 16.56GB0006640972 B: Financial Instruments Resulting situation after the triggering transaction (xii) Type of Expiration Date Exercise/Conversion Number of voting % of voting financial (xiii) Period/ Date (xiv) rights that may be rights instrument acquired if the instrument is exercised/ converted. N/A N/A N/A N/A N/A Total (A+B) Number of voting rights % of voting rights 4,205,500 16.56 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable (xv): Held by Aberforth Partners LLP Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: In addition, Aberforth LLP is interested in a further 704,500 shares althoughwe do not have access to the voting rights of theses shares. Aberforth PartnersLLP is, therefore interested on a total of 4,910,000 shares of the abovecompany. This interest arises as a result of the discretionary investment management powers that we can exercise over the funds of our client. AberforthPartners LLP is not the beneficial owner of these shares. 14. Contact name: David Holland, Aberforth Partners LLP 15. Contact telephone number: 0131 220 0733 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Jun 20267:00 amRNSDirector/PDMR Shareholding
20th May 20261:14 pmRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
15th May 20268:02 amRNSDirector/PDMR Shareholding
14th Apr 20269:27 amRNSAnnual Financial Report
25th Mar 20262:05 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSFinal Results
11th Mar 20267:00 amRNSFinal Results
18th Feb 20267:00 amRNSHolding(s) in Company
10th Feb 20262:54 pmRNSHolding(s) in Company
22nd Jan 20268:54 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
5th Jan 20262:39 pmRNSBlock listing Interim Review
22nd Dec 20252:41 pmRNSHolding(s) in Company
22nd Dec 20252:41 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSChair Succession
11th Nov 20257:00 amRNSTrading Statement
24th Oct 20258:31 amRNSHolding(s) in Company
21st Oct 20254:04 pmRNSHolding(s) in Company
29th Aug 20253:52 pmRNSHolding(s) in Company
29th Aug 20257:41 amRNSHolding(s) in Company
29th Aug 20257:35 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSHalf-year Report
23rd Jul 20259:09 amRNSBlock listing Interim Review
4th Jun 20258:31 amRNSDirector/PDMR Shareholding
21st May 20251:02 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Statement
2nd May 20253:47 pmRNSDirector/PDMR Shareholding
2nd May 20257:47 amRNSChange of Adviser
15th Apr 20259:30 amRNSDoc re Report and Accounts
3rd Apr 20252:09 pmRNSHolding(s) in Company
28th Mar 20258:44 amRNSEBT Purchase
27th Mar 20258:08 amRNSDirector/PDMR Shareholding
21st Mar 20258:09 amRNSEBT Purchase
12th Mar 20257:00 amRNSDirectorate Change
12th Mar 20257:00 amRNSFinal Results
4th Mar 20254:06 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Statement
17th Dec 20242:53 pmRNSDirector/PDMR Shareholding
6th Dec 20249:03 amRNSHolding(s) in Company
5th Dec 20242:58 pmRNSEBT Purchase
14th Nov 20241:57 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Statement
7th Nov 20243:00 pmRNSHolding(s) in Company
6th Nov 20249:55 amRNSHolding(s) in Company
29th Oct 20241:29 pmRNSHolding(s) in Company
21st Oct 20248:32 amRNSEBT Purchase
18th Oct 20247:00 amRNSDirectorate Change
17th Sep 20248:32 amRNSEBT Purchase
2nd Sep 20249:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.